PaxMedica, Inc. Common Stock (PXMD)’in fiyatı nedir?

PaxMedica, Inc. Common Stock (PXMD)’in fiyatı $0.0005’dir

PaxMedica, Inc. Common Stock (PXMD)’in piyasa değeri nedir?

PaxMedica, Inc. Common Stock (PXMD)’in piyasa değeri $63.13K’dir.

PaxMedica, Inc. Common Stock (PXMD) Tedavüldeki Hisseler

PaxMedica, Inc. is a biopharmaceutical company currently in the clinical development phase, dedicated to advancing anti-purinergic drug therapies (APTs). These innovative treatments are specifically designed to address complex neurological disorders presenting with stubborn and persistent symptoms. The company's primary investigative drug is PAX-101, an intravenous (IV) form of suramin, which is being explored for a variety of conditions. These include autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, post-COVID-19 syndrome (commonly known as "long COVID"), and human African trypanosomiasis. Furthermore, PaxMedica is also developing PAX-102, an intranasal version of suramin, intended for various neurological applications. The company, which was incorporated in 2018 and has its headquarters in Tarrytown, New York, previously operated as Purinix Pharmaceuticals LLC before rebranding to PaxMedica, Inc. in April 2020. It functions as a subsidiary of Tardimed Sciences LLC.

Yıl	Tedavüldeki Hisse Sayısı	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Tedavüldeki Hisse Sayısı

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Tedavüldeki Hisse Sayısı	Fark	Ülke
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	0.00	-	BE

Şirket

Tedavüldeki Hisse Sayısı

Fark

Ülke